April 15, 2009
Chile approves ISA vaccine
Chile has approved an infectious salmon anaemia (ISA) vaccine developed by domestic veterinary pharmaceutical company Centrovet.
The vaccine was developed after two years of research and US$6 million in investment. The vaccine was produced from a viral strain present in salmon from southern Chile. Centrovet hopes to produce 60 million doses this year.
The company's laboratory manager said the vaccine is the first immunological alternative of its kind developed in Chile to fight the ISA virus, a pathogen that has disrupted and severely damaged Chile's salmon farming industry since mid-2007.
